Company Filing History:
1 out of 517 
1 out of 165 
1 out of 832,891 Years Active: 2003-2010
Title: Michelle V Letarte: Innovator in Hypertensive Disorders
Introduction: Michelle V Letarte is a distinguished inventor based in Toronto, Canada. With a strong focus on improving health outcomes related to pregnancy, she has made significant contributions through her patents involving the treatment of pregnancy-related hypertensive disorders.
Latest Patents: Michelle holds two patents, with her latest work focusing on innovative methods for addressing hypertensive disorders during pregnancy. One patent details the use of compounds that bind soluble endoglin and sFlt-1, offering new therapeutic avenues for conditions such as pre-eclampsia and eclampsia. This patent emphasizes methods to alter the expression levels or biological activity of these compounds, potentially transforming care for affected mothers. Additionally, her work includes the genomic sequence encoding endoglin and its fragments, further elucidating the biological underpinnings of these disorders.
Career Highlights: Throughout her career, Michelle has collaborated with renowned institutions, including Beth Israel Deaconess Medical Center and The Hospital for Sick Children. Her experience in these leading research environments showcases her commitment to advancing medical science, especially in maternal health.
Collaborations: Michelle has worked alongside esteemed colleagues such as S Ananth Karumanchi and Vikas P Sukhatme. This collaboration underscores the importance of teamwork and shared expertise in driving innovation in healthcare.
Conclusion: Michelle V Letarte is an exemplary figure in the field of medical innovation. Her patented inventions have the potential to change the landscape of treatment for pregnancy-related hypertensive disorders, benefiting countless families. As she continues her work, her contributions promise to pave the way for future advancements in maternal health.